Eatontown Primary Care, LLC
Eatontown Primary Care, LLC was paid $2.52M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoEATONTOWN PRIMARY CARE, LLC
EATONTOWN, NJ 07724
EATONTOWN, NJ 07724
33aNPI1902092281assigned 09/19/2007
33bProvider typeSpecialist
28Total paid$2.52M
24GClaims50,978
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New Jersey
Rank by total paid#23 of 378
Median peer was paid$63K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,752 | $467K | |
| 2019 | 9,230 | $613K | |
| 2020 | 7,957 | $437K | |
| 2021 | 6,906 | $286K | |
| 2022 | 6,517 | $310K | |
| 2023 | 7,287 | $245K | |
| 2024incomplete | 3,329 | $162K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 13,844 | 11,218 | $700K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 13,864 | 9,892 | $437K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12% | 2,087 | 1,850 | $305K |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 7.5% | 583 | 420 | $189K |
| 76942 | 7.0% | 1,408 | 857 | $177K | |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 3.7% | 163 | 129 | $93K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.0% | 1,077 | 947 | $75K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.9% | 468 | 388 | $72K |
| 20610 | 2.5% | 1,699 | 995 | $63K | |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 2.2% | 58 | 46 | $56K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 2,337 | 1,757 | $47K |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 1.8% | 227 | 101 | $45K |
39 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.5% | 606 | $39K |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 1.5% | 176 | $37K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,672 | $17K |
| 20611 | <1% | 1,172 | $15K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,526 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 689 | $13K |
| 90670 | <1% | 106 | $12K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | <1% | 101 | $10K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 175 | $10K |
| 97760 | <1% | 829 | $10K | |
| 93923 | <1% | 142 | $9K | |
| 95924 | <1% | 149 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 520 | $7K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 146 | $7K |
| E0730 | Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation | <1% | 46 | $6K |
| J1740 | Injection, ibandronate sodium, 1 mg | <1% | 59 | $6K |
| 93922 | <1% | 165 | $5K | |
| J0897 | Injection, denosumab, 1 mg | <1% | 14 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 47 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,068 | $4K |
| 90688 | <1% | 286 | $4K | |
| 90674 | <1% | 168 | $3K | |
| 90756 | <1% | 146 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 26 | $2K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 177 | $2K |
| 64550 | <1% | 109 | $2K | |
| 93886 | <1% | 14 | $1K | |
| 36410 | <1% | 60 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 130 | $855.18 |
| 93000 | <1% | 59 | $796.71 | |
| 20605 | <1% | 15 | $452.15 | |
| 93040 | <1% | 79 | $421.55 | |
| 96401 | <1% | 15 | $346.89 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 187 | $266.96 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 24 | $163.68 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $127.12 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 76 | $61.70 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 14 | $16.80 |
| G0008 | Administration of influenza virus vaccine | <1% | 99 | $9.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANNA, MANAR (MD)